This Genetic Technology TOE provides insights into recent developments across stem cell technologies. It encompasses innovations in delivery platforms, iPSC therapeutics, bioengineering methods, and mesenchymal stem cell therapies. The TOE also provides a summary of key stem cell therapies.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions.
The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords:
- Stem Cells
- iPSC
- Bioengineering
- Mesenchymal Stem Cell
Table of Contents
1. Innovations in Stem Cell Therapy
Recent Advances in Stem Cell Technologies
- Injectable 3D Cell Delivery Matrix
- iPSCs Derived Cardiomyocytes for Heart Failure
- Bioengineered Stem Cell and Tissue-based Platforms
- Placenta-derived, Mesenchymal-like Adherent Stromal Cells
Clinical Trial Analysis and Key Contacts
- Clinical Trial Analysis for Stem Cell Therapy
- Key Contacts
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Renevia
- Fujifilm
- Osiris
- Pluristem
